The phrase "agents for development" is correct and usable in written English.
It can be used in contexts discussing individuals or organizations that facilitate or promote growth and progress in various fields, such as social, economic, or community development.
Example: "Non-governmental organizations often act as agents for development, helping to implement projects that improve local infrastructure and education."
Alternatives: "catalysts for growth" or "facilitators of progress".
Moreover, highly potent siRNAs identified here may serve as novel agents for development of nucleic acid-based HBV therapy.
The synthesis and biological studies provided an interesting new class of antitubulin agents for development of lead compounds and also a direction for further structure modification to obtain more potent anti-cancer drugs.
The current article is not meant to provide an exhaustive overview of green synthesis of nanoparticles, but to present the pertinent role of plant terpenoids in the biosynthesis of AgNPs, as capping and reducing agents for development of uniform size and shape AgNPs.
The approaches used and problems presented may be of general interest to scientists in related fields and those considering submitting agents for development.
The Banco Nacional de Desenvolvimento Econômico e Social (Brazilian Development Bank - BNDES) is the main financing agent for development in Brazil.
The impression that progesterone is an etiologic agent for development of breast cancer is based in part on the increased proliferative activity observed in normal breast during the luteal phase of the menstrual cycle associated with rising progesterone levels [ 61].
Child participation, indeed, enhances the social and psychological development of children improving their self confidence and making them active agents for the development of the society they live in".
Thus, these compounds could become multifunctional agents for further development for the treatment of AD.
We also discuss strategies for combination chemo-immunotherapy, and we outline approaches to identify new immunogenic chemotherapeutic agents for drug development.
Owing to their outstanding inherent thermal stability and proteolytic resistance, as well as their small size of only around 30 amino acid residues, cystine knot miniproteins are an attractive class of agents for the development of peptide-based pharmaceuticals.
Thus, DST involves broadening the conception of what the causal agents for organismic development are.
